The Modulo Bio team with CEO Michael Horowitz (fourth from right in semicircle)
Exclusive: With $8M, neuro startup Modulo Bio emerges to test small molecules for ALS, dementia in CEO’s personal mission
Embarking on a personal mission after his best friend’s mother was diagnosed with a mutation-driven case of frontotemporal dementia, Michael Horowitz has pulled together …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.